Refers to the presence of immunoglobulinA human blood donor product made up of immunoglobulins (IgG and IgM antibodies) derived from plasma that can be administered intravenously (IVIG) or subcutaneously (SCIG). For myelin oligodendrocyte glycoprotein antibody disease (MOGAD), it is used as an immunomodulator to reduce disease activity. Sometimes used for acute attacks or as an ongoing preventative treatment. G (IgG) antibodiesA protective protein produced by your immune system that attaches to antigens (foreign substances), such as bacteria and toxins, and removes them from your body. In myelin oligodendrocyte glycoproten antibody disease (MOGAD), the body incorrectly produces an antibody that targets myelin oligodendrocyte glycoprotein, a component of the myelin sheath in the central nervous system. in the blood that are specifically targeted against myelin oligodendrocyte glycoprotein (MOG)A type of protein involved in cell adhesion. Present throughout myelin sheaths., a protein found in the central nervous systemNerve tissue that resides in and composes the brain, spinal cord, and optic nerve
Myelin Oligodendrocyte Glycoprotein Immunoglobulin G (MOG-IgG)
Related Posts
Gabriela’s Story: A Story of Faith, Strength, and Resilience
My name is Gabriela Nunez, though most people know me as Gabby. I am 26 years old, a wife, and a proud mother of three
Eight Years Old and Running for Her Brother
When Aria laced up her trainers for the AJ Bell Great Manchester Run, she wasn’t just racing — she was advocating for her twin brother
Global Leaders in MOGAD Research Convened May 14-16, 2026
Leading international clinicians, researchers, advocates, and industry collaborators gathered in Cambridge, Massachusetts, for two major back-to-back MOGAD meetings focused on research priorities, clinical trials, therapeutic
